ZEVIN ASSET MANAGEMENT LLC historic quarter change: Foreign Other Stocks, Added
In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, ZEVIN ASSET MANAGEMENT LLC opened 15 positions, added to 65, reduced 65 and sold out of 30.
- Q2 2025: Stock Keyence; Country of operation —; Class COM; Shares before 26,725.
- Q4 2024: Stock Keyence; Country of operation —; Class COM; Shares before 24,913.
- Q3 2024: Stock Keyence; Country of operation —; Class COM; Shares before 24,476.
- Q2 2024: Stock Croda; Country of operation —; Class COM; Shares before 83,129.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1394096), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-06); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-07); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-10); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-06); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-06); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-10); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-07); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-29); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-07); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-08); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-02); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-08); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-12); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-05); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-07); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-10); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-06); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-11); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-13); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-10); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2007-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2025 | Keyence
CUSIP J32491102 | | COM | 26,725 | 26,963 | +238 | $10,421 | $10,829 | +$408 | 2025-08-06 |
|---|
| Q4 2024 | Keyence
CUSIP J32491102 | | COM | 24,913 | 27,668 | +2,755 | $11,857 | $11,212 | -$645 | 2025-02-10 |
|---|
| Q3 2024 | Keyence
CUSIP J32491102 | | COM | 24,476 | 24,913 | +437 | $10,736 | $11,857 | +$1,121 | 2024-11-07 |
|---|
| Q2 2024 | Croda
CUSIP G25536155 | | COM | 83,129 | 83,912 | +783 | $5,163 | $4,190 | -$973 | 2024-07-29 |
|---|
| Q2 2024 | Keyence
CUSIP J32491102 | | COM | 24,080 | 24,476 | +396 | $11,150 | $10,736 | -$414 | 2024-07-29 |
|---|
| Q1 2024 | Keyence
CUSIP J32491102 | | COM | 22,405 | 24,080 | +1,675 | $9,874 | $11,150 | +$1,276 | 2024-05-09 |
|---|
| Q1 2024 | Croda
CUSIP G25536155 | | COM | 62,128 | 83,129 | +21,001 | $4,014 | $5,163 | +$1,149 | 2024-05-09 |
|---|
| Q3 2016 | Novozymes A/S B Shs sedol# B79
CUSIP K7317J133 | | COM | 4,200 | 4,940 | +740 | $200,000 | $218,000 | +$18,000 | 2016-11-07 |
|---|
| Q3 2016 | Astellas Pharma Japan sedol 69
CUSIP J03393105 | | COM | 21,500 | 22,000 | +500 | $335,000 | $342,000 | +$7,000 | 2016-11-07 |
|---|
| Q2 2016 | Ramsay Health Care Ltd sedol#6
CUSIP Q7982Y104 | | COM | 101,855 | 102,200 | +345 | $4,808,000 | $5,461,000 | +$653,000 | 2016-08-08 |
|---|
| Q2 2016 | Swiss RE AG Sedol# B545MG5 CH
CUSIP H8431B109 | | COM | 95,800 | 96,955 | +1,155 | $8,893,000 | $8,435,000 | -$458,000 | 2016-08-08 |
|---|
| Q2 2016 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 200,395 | 203,745 | +3,350 | $8,544,000 | $8,502,000 | -$42,000 | 2016-08-08 |
|---|
| Q1 2016 | Swiss RE AG Sedol# B545MG5 CH
CUSIP H8431B109 | | COM | 94,270 | 95,800 | +1,530 | $9,243,000 | $8,893,000 | -$350,000 | 2016-05-02 |
|---|
| Q4 2015 | Swiss RE AG Sedol# B545MG5 CH
CUSIP H8431B109 | | COM | 92,370 | 94,270 | +1,900 | $7,903,000 | $9,243,000 | +$1,340,000 | 2016-02-08 |
|---|
| Q4 2015 | Ramsay Health Care Ltd sedol#6
CUSIP Q7982Y104 | | COM | 99,890 | 102,355 | +2,465 | $4,101,000 | $5,059,000 | +$958,000 | 2016-02-08 |
|---|
| Q4 2015 | Fanuc 6954 sedol# 6356934 JP
CUSIP J13440102 | | COM | 28,700 | 28,900 | +200 | $4,389,000 | $5,064,000 | +$675,000 | 2016-02-08 |
|---|
| Q4 2015 | Novozymes A/S B Shs sedol# B79
CUSIP K7317J133 | | COM | 61,230 | 64,070 | +2,840 | $2,665,000 | $3,083,000 | +$418,000 | 2016-02-08 |
|---|
| Q4 2015 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 205,090 | 207,685 | +2,595 | $9,322,000 | $9,582,000 | +$260,000 | 2016-02-08 |
|---|
| Q4 2015 | Rockwool Intl A/S Sedol# 47134
CUSIP K8254S144 | | COM | 9,740 | 9,905 | +165 | $1,387,000 | $1,397,000 | +$10,000 | 2016-02-08 |
|---|
| Q4 2015 | Singapore Telecom LTD
CUSIP Y79985209 | | COM | 32,000 | 34,300 | +2,300 | $81,000 | $89,000 | +$8,000 | 2016-02-08 |
|---|
| Q3 2015 | Fanuc 6954 sedol# 6356934 JP
CUSIP J13440102 | | COM | 12,300 | 28,700 | +16,400 | $2,521,000 | $4,389,000 | +$1,868,000 | 2015-11-12 |
|---|
| Q3 2015 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 198,590 | 205,090 | +6,500 | $8,537,000 | $9,322,000 | +$785,000 | 2015-11-12 |
|---|
| Q3 2015 | Ramsay Health Care Ltd sedol#6
CUSIP Q7982Y104 | | COM | 99,325 | 99,890 | +565 | $4,693,000 | $4,101,000 | -$592,000 | 2015-11-12 |
|---|
| Q3 2015 | Novozymes A/S B Shs sedol# B79
CUSIP K7317J133 | | COM | 47,975 | 61,230 | +13,255 | $2,279,000 | $2,665,000 | +$386,000 | 2015-11-12 |
|---|
| Q3 2015 | Imerys sedol # B011GL4 FR
CUSIP F49644101 | | COM | 33,440 | 34,790 | +1,350 | $2,556,000 | $2,229,000 | -$327,000 | 2015-11-12 |
|---|
| Q3 2015 | Swiss RE AG Sedol# B545MG5 CH
CUSIP H8431B109 | | COM | 91,935 | 92,370 | +435 | $8,140,000 | $7,903,000 | -$237,000 | 2015-11-12 |
|---|
| Q3 2015 | Nordea Bank AB ORD 5380031SE
CUSIP W57996105 | | COM | 192,475 | 196,955 | +4,480 | $2,398,000 | $2,189,000 | -$209,000 | 2015-11-12 |
|---|
| Q3 2015 | Rockwool Intl A/S Sedol# 47134
CUSIP K8254S144 | | COM | 8,890 | 9,740 | +850 | $1,333,000 | $1,387,000 | +$54,000 | 2015-11-12 |
|---|
| Q3 2015 | Svenska Handelsbanken ORD 5703
CUSIP W9112U104 | | COM | 175,290 | 177,220 | +1,930 | $2,556,000 | $2,533,000 | -$23,000 | 2015-11-12 |
|---|
| Q2 2015 | Roche Holdings Switzerland 711
CUSIP H69293217 | | COM | 48,050 | 59,625 | +11,575 | $13,263,000 | $16,716,000 | +$3,453,000 | 2015-08-05 |
|---|
| Q2 2015 | Chubb Corporation
CUSIP 171232101 | | COM | 65,674 | 74,164 | +8,490 | $6,640,000 | $7,056,000 | +$416,000 | 2015-08-05 |
|---|
| Q2 2015 | Jasa Marga (JSMR IJ) sedol B28
CUSIP Y71285103 | | COM | 3,297,000 | 3,416,800 | +119,800 | $1,813,000 | $1,401,000 | -$412,000 | 2015-08-05 |
|---|
| Q2 2015 | Ramsay Health Care Ltd sedol#6
CUSIP Q7982Y104 | | COM | 98,575 | 99,325 | +750 | $5,064,000 | $4,693,000 | -$371,000 | 2015-08-05 |
|---|
| Q2 2015 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 194,890 | 198,590 | +3,700 | $8,211,000 | $8,537,000 | +$326,000 | 2015-08-05 |
|---|
| Q2 2015 | Novozymes A/S B Shs sedol# B79
CUSIP K7317J133 | | COM | 46,575 | 47,975 | +1,400 | $2,133,000 | $2,279,000 | +$146,000 | 2015-08-05 |
|---|
| Q2 2015 | Imerys sedol # B011GL4 FR
CUSIP F49644101 | | COM | 32,960 | 33,440 | +480 | $2,456,000 | $2,556,000 | +$100,000 | 2015-08-05 |
|---|
| Q2 2015 | Nordea Bank AB ORD 5380031SE
CUSIP W57996105 | | COM | 188,225 | 192,475 | +4,250 | $2,298,000 | $2,398,000 | +$100,000 | 2015-08-05 |
|---|
| Q1 2015 | Swiss RE AG Sedol# B545MG5 CH
CUSIP H8431B109 | | COM | 90,585 | 92,595 | +2,010 | $7,623,000 | $8,971,000 | +$1,348,000 | 2015-05-07 |
|---|
| Q1 2015 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 194,300 | 194,890 | +590 | $6,931,000 | $8,211,000 | +$1,280,000 | 2015-05-07 |
|---|
| Q1 2015 | Fanuc 6954 sedol# 6356934 JP
CUSIP J13440102 | | COM | 12,200 | 12,300 | +100 | $2,048,000 | $2,692,000 | +$644,000 | 2015-05-07 |
|---|
| Q1 2015 | Roche Holdings Switzerland
CUSIP H69293217 | | COM | 46,890 | 48,050 | +1,160 | $12,705,000 | $13,263,000 | +$558,000 | 2015-05-07 |
|---|
| Q1 2015 | Ramsay Health Care Ltd sedol#6
CUSIP Q7982Y104 | | COM | 96,690 | 98,575 | +1,885 | $4,518,000 | $5,064,000 | +$546,000 | 2015-05-07 |
|---|
| Q1 2015 | Novozymes A/S B Shs sedol# B01
CUSIP K7317J133 | | COM | 44,700 | 46,575 | +1,875 | $1,877,000 | $2,133,000 | +$256,000 | 2015-05-07 |
|---|
| Q1 2015 | Nordea Bank AB ORD 5380031SE
CUSIP W57996105 | | COM | 179,750 | 188,225 | +8,475 | $2,094,000 | $2,298,000 | +$204,000 | 2015-05-07 |
|---|
| Q1 2015 | Imerys sedol # B011GL4 FR
CUSIP F49644101 | | COM | 32,650 | 32,960 | +310 | $2,436,000 | $2,456,000 | +$20,000 | 2015-05-07 |
|---|
| Q1 2015 | Chubb Corporation
CUSIP 171232101 | | COM | 64,114 | 65,674 | +1,560 | $6,634,000 | $6,640,000 | +$6,000 | 2015-05-07 |
|---|
| Q4 2014 | Chubb Corporation
CUSIP 171232101 | | COM | 63,919 | 64,114 | +195 | $5,822,000 | $6,634,000 | +$812,000 | 2015-02-10 |
|---|
| Q4 2014 | Swiss RE AG
CUSIP H8431B109 | | COM | 87,585 | 90,585 | +3,000 | $6,980,000 | $7,623,000 | +$643,000 | 2015-02-10 |
|---|
| Q3 2014 | Chubb Corporation
CUSIP 171232101 | | COM | 2,839 | 63,919 | +61,080 | $262,000 | $5,822,000 | +$5,560,000 | 2014-11-06 |
|---|
| Q3 2014 | Swiss RE AG
CUSIP H8431B109 | | COM | 24,240 | 87,585 | +63,345 | $2,157,000 | $6,980,000 | +$4,823,000 | 2014-11-06 |
|---|
| Q3 2014 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 193,800 | 195,400 | +1,600 | $8,165,000 | $7,578,000 | -$587,000 | 2014-11-06 |
|---|
| Q3 2014 | Roche Holdings Switzerland
CUSIP H69293217 | | COM | 45,795 | 47,955 | +2,160 | $13,659,000 | $14,208,000 | +$549,000 | 2014-11-06 |
|---|
| Q2 2014 | Aust&New Zealnd Bkg Ordf Sedol
CUSIP Q09504137 | | COM | 108,850 | 114,250 | +5,400 | $3,335,000 | $3,595,000 | +$260,000 | 2014-08-11 |
|---|
| Q2 2014 | Astellas Pharma Japan sedol 69
CUSIP J03393105 | | COM | 5,200 | 26,000 | +20,800 | $299,000 | $342,000 | +$43,000 | 2014-08-11 |
|---|
| Q1 2014 | Volkswagen Ag Preferred sedol#
CUSIP D94523103 | | COM | 62,705 | 63,110 | +405 | $17,651,000 | $16,399,000 | -$1,252,000 | 2014-05-13 |
|---|
| Q1 2014 | Novo-Nordisk A/S Sedol# 707752
CUSIP K72807132 | | COM | 8,725 | 43,625 | +34,900 | $1,610,000 | $1,988,000 | +$378,000 | 2014-05-13 |
|---|
| Q4 2013 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 220,200 | 228,700 | +8,500 | $8,034,000 | $9,091,000 | +$1,057,000 | 2014-02-10 |
|---|
| Q4 2013 | Shiseido Co Ltd
CUSIP J74358144 | | COM | 184,200 | 184,275 | +75 | $3,311,000 | $2,892,000 | -$419,000 | 2014-02-10 |
|---|
| Q4 2013 | Daiichi Sankyo Japan sedol BOJ
CUSIP J11257102 | | COM | 245,150 | 245,250 | +100 | $4,442,000 | $4,488,000 | +$46,000 | 2014-02-10 |
|---|
| Q3 2013 | Volkswagen Ag Preferred sedol#
CUSIP D94523103 | | COM | 62,890 | 63,700 | +810 | $12,704,000 | $15,034,000 | +$2,330,000 | 2013-11-12 |
|---|
| Q3 2013 | Shiseido Co Ltd
CUSIP J74358144 | | COM | 182,200 | 184,200 | +2,000 | $2,709,000 | $3,311,000 | +$602,000 | 2013-11-12 |
|---|
| Q3 2013 | Daiichi Sankyo Japan sedol BOJ
CUSIP J11257102 | | COM | 242,150 | 245,150 | +3,000 | $4,037,000 | $4,442,000 | +$405,000 | 2013-11-12 |
|---|
| Q3 2013 | Astellas Pharma Japan sedol 69
CUSIP J03393105 | | COM | 109,975 | 111,275 | +1,300 | $5,967,000 | $5,670,000 | -$297,000 | 2013-11-12 |
|---|
| Q3 2013 | Seven & I Holdings Ltd 3382 JP
CUSIP J7165H108 | | COM | 216,400 | 220,200 | +3,800 | $7,897,000 | $8,034,000 | +$137,000 | 2013-11-12 |
|---|
| Q3 2013 | Grupo Aero. del Sureste 263934
CUSIP P4950Y100 | | COM | 256,845 | 259,770 | +2,925 | $2,844,000 | $2,823,000 | -$21,000 | 2013-11-12 |
|---|